Tizanidine Tablet
Product Images NDC 29300-168

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 29300-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01

Chemical structure of Tizanidine hydrochloride showing a chlorinated benzene ring fused to an imidazoline and thiazole moiety with attached functional groups.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02

A line graph depicting plasma Tizanidine concentration (ng/mL) over time (hours) from dosing. It compares four different conditions: 2 x 4 mg Tizanidine tablets with and without food, and 2 x 4 mg Tizanidine capsules with and without food, showing concentration changes up to 24 hours post-dose.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03

Line graph depicting improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph shows the degree of improvement at multiple time points up to 6 hours following administration.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04

A line graph showing the improvement in Ashworth Score over time for two groups: Tizanidine (mean dose 28.8 mg) and placebo. The x-axis marks study weeks (end of titration, maintenance, and endpoint), and the y-axis shows improvement from -6 to 2. Tizanidine demonstrates greater improvement at all time points compared to placebo, with error bars indicating variability.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 06

Label for Tizanidine Tablets, USP 2 mg by Unichem Pharmaceuticals (USA), Inc. The label shows NDC 29300-168-15 and indicates each tablet contains 2 mg tizanidine base. The package contains 150 tablets. Storage instructions and a warning that the tablets are not interchangeable with capsules are included. Manufacturer details are listed as Unichem Laboratories Ltd., India.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 07

Label for Tizanidine Tablets, USP 4 mg, by Unichem Pharmaceuticals (USA), Inc. The label includes the NDC number 29300-169-15 and states each tablet contains 4 mg tizanidine base (4.576 mg tizanidine hydrochloride). The package contains 150 tablets. Storage instructions specify 20° to 25°C (68° to 77°F) in a tight, light-resistant container. A warning notes that tizanidine tablets are not interchangeable with capsules. Manufacturer information includes Unichem Laboratories Ltd. in India and Unichem Pharmaceuticals (USA), Inc. in New Jersey.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.